510(k) K252533
K252533 is an FDA 510(k) premarket notification submitted by Edwards Lifesciences for the device "HemoSphere Alta Advanced Monitoring Platform (ALTAALL1; ALTACR1; ALTASR1)". The FDA issued a decision of Substantially Equivalent on Dec 18, 2025. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Edwards Lifesciences has 157 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 18, 2025
- Date Received
- Aug 12, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type
- 510(k)
Need the full FDA record for Edwards Lifesciences? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.